PRKDC and melanoma: Notably, we present evidence that DNA-PK inhibition has potent immunostimulatory effects on melanoma cells, as demonstrated through investigation of the mechanistic underpinnings of DNA-PK inhibition on TIL infiltration, tumor antigen expression, and TCRvβ diversity and functional capacity.